Waddill William D.

CIK 00015533386 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001553338

Recent Transactions

50 trades

Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-02+2,695→ 7,825 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-02+3,762→ 3,762 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16+7,819→ 64,930 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-10-10−12,000→ 0 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-10-10$87.81/sh−8,000→ 5,130 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-10-10$69.25/sh−4,000→ 13,130 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-10-10$6.98/sh+12,000→ 17,130 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-09-22$64.25/sh−4,000→ 5,130 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-08-27$59.25/sh−4,000→ 9,130 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2025-06-05+55,000→ 55,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-03-17$54.25/sh−4,000→ 13,130 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-01-02+5,130→ 17,130 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-18$22.99/sh+16,733→ 57,111 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-17$22.04/sh−3,747→ 40,378 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-16$21.90/sh−3,748→ 44,125 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-09-10$12.88/sh+8,000→ 20,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-09-10−8,000→ 0 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-09-10$45.00/sh−8,000→ 12,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-07-24−8,000→ 8,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-07-24$40.00/sh−8,000→ 12,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-07-24$12.88/sh+8,000→ 20,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-06-07$12.88/sh+8,000→ 20,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-06-07−8,000→ 16,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-06-07$35.00/sh−8,000→ 12,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2024-06-05+44,000→ 44,000 total
Award
Turnstone Biologics Corp.
Stock Option (Right to Buy)
2024-06-03+12,770→ 12,770 total
Award
Turnstone Biologics Corp.
Stock Option (Right to Buy)
2024-04-15+25,540→ 25,540 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-03-01$31.34/sh−12,975→ 12,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-03-01$6.09/sh+12,975→ 24,975 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-03-01−12,975→ 0 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-11$37.81/sh−2,634→ 49,170 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-11$38.59/sh−1,300→ 47,870 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-12-15$25.41/sh+14,987→ 51,804 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2023-06-08+24,000→ 24,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-01-16+30,000→ 30,000 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-01-10+7,867→ 36,817 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-01-10+4,593→ 4,593 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-01-09$30.00/sh−3,200→ 28,950 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2022-06-09+24,000→ 24,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-05-03−12,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2022-05-03$8.59/sh+12,000→ 12,000 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-07+6,400→ 32,150 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-03$64.23/sh−2,100→ 28,150 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-03$66.25/sh−272→ 25,750 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2022-01-03$65.01/sh−2,128→ 26,022 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2021-08-12+20,000→ 20,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 total

Companies

Recent Filings

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160

View on SEC.gov